Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
CDC: Lasting COVID-19 symptoms tied to age, sex, race factors
By
Alicia Lasek
Sep 21, 2021
Investigators examined recovered COVID-19 patients in Long Beach California. Fully one third of participants reported having at least one symptom of post-acute sequelae, commonly called “long COVID-19,”...
Orthostatic intolerance common in post-acute patients, signaling need for clinical workup
By
Alicia Lasek
Sep 02, 2021
Older rehabilitation patients should be assessed for symptoms of orthostatic intolerance upon admission, a new study suggests.
Bone health intervention cuts fracture risk in men treated for prostate cancer: study
By
Alicia Lasek
Apr 05, 2022
Early intervention with bone mineral density screening may help prevent major fractures in older men treated with androgen deprivation therapy, investigators say.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
Anxiety meds, antidepressants tied to post-surgery delirium in seniors: study
By
Alicia Lasek
Dec 13, 2021
Older patients should be temporarily weaned off these drugs whenever possible — well before their scheduled surgery, the researchers say.
Brain fog may last 8 months after bout with COVID-19, patient study finds
By
Alicia Lasek
Oct 25, 2021
Many recovered patients had problems with executive functioning, which can include trouble with organization, listening and attention, as well as processing speed, category fluency, memory encoding, and...
CDC issues clinical guidance for treating post-COVID conditions
By
Alicia Lasek
Jun 17, 2021
Many cases can be managed by primary care providers, federal health officials say. A lack of lab or imaging abnormalities does not invalidate the existence or severity of a patient’s symptoms or conditions,...